{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:31Z","timestamp":1786981291348,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Non-competitive internal BST grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01901-2","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T17:10:37Z","timestamp":1750353037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["BK Virus-Specific T Cell Response Associated with HLA Genotypes, RhD Status, and CMV or EBV Serostatus in Healthy Donors for Optimized Cell Therapy"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0117-0007","authenticated-orcid":false,"given":"Rut","family":"Mora-Buch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tom\u00e1s-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-7863","authenticated-orcid":false,"given":"Helena","family":"Pasamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-1333","authenticated-orcid":false,"given":"Emma","family":"Enrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8043-8187","authenticated-orcid":false,"given":"Cleof\u00e9","family":"Pe\u00f1a-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3099-067X","authenticated-orcid":false,"given":"Francesc","family":"Rudilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"1","key":"1901_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jmv.10450","volume":"71","author":"WA Knowles","year":"2003","unstructured":"Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, Brown DWG, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol. 2003;71(1):115\u201323.","journal-title":"J Med Virol"},{"issue":"4","key":"1901_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/infdis\/147.4.676","volume":"147","author":"PM Chesters","year":"1983","unstructured":"Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 1983;147(4):676\u201384.","journal-title":"J Infect Dis"},{"issue":"9","key":"1901_CR3","doi-asserted-by":"publisher","first-page":"e13528","DOI":"10.1111\/ctr.13528","volume":"33","author":"HH Hirsch","year":"2019","unstructured":"Hirsch HH, Randhawa PS. BK polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):e13528.","journal-title":"Clin Transplant"},{"issue":"4","key":"1901_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1399-0012.2006.00519.x","volume":"20","author":"GJ Alangaden","year":"2006","unstructured":"Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20(4):401\u20139.","journal-title":"Clin Transplant"},{"issue":"2","key":"1901_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1309\/AJCP63VDFCKCRUUL","volume":"133","author":"CJ Bechert","year":"2010","unstructured":"Bechert CJ, Schnadig VJ, Payne DA, Dong J. Monitoring of BK viral load in renal allograft recipients by real-time PCR assays. Am J Clin Pathol. 2010;133(2):242\u201350.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"1901_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.idc.2010.02.003","volume":"24","author":"I Helanter\u00e4","year":"2010","unstructured":"Helanter\u00e4 I, Egli A, Koskinen P, Lautenschlager I, Hirsch HH. Viral impact on long-term kidney graft function. Infect Dis Clin North Am. 2010;24(2):339\u201371.","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"1901_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1111\/ajt.13252","volume":"15","author":"T Schachtner","year":"2015","unstructured":"Schachtner T, Stein M, Babel N, Reinke P. The loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased Risk of BKV replication. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2015;15(8):2159\u201369.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"12","key":"1901_CR8","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","volume":"10","author":"S Schaub","year":"2010","unstructured":"Schaub S, Hirsch HH, Dickenmann M, Steiger J, Mihatsch MJ, Hopfer H, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2010;10(12):2615\u201323.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"1901_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2018.10.002","volume":"109","author":"B Demey","year":"2018","unstructured":"Demey B, Tinez C, Fran\u00e7ois C, Helle F, Choukroun G, Duverlie G, et al. Risk factors for BK virus viremia and nephropathy after kidney transplantation: A systematic review. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2018;109:6\u201312.","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"issue":"9","key":"1901_CR10","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","volume":"5","author":"DL Bohl","year":"2005","unstructured":"Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Schnitzler MA, Major EO, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2005;5(9):2213\u201321.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"6","key":"1901_CR11","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1097\/TP.0000000000001261","volume":"101","author":"JR Abend","year":"2017","unstructured":"Abend JR, Changala M, Sathe A, Casey F, Kistler A, Chandran S, et al. Correlation of BK virus neutralizing serostatus with the incidence of BK Viremia in kidney transplant recipients. Transplantation. 2017;101(6):1495\u2013505.","journal-title":"Transplantation"},{"issue":"8","key":"1901_CR12","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2215\/CJN.00770112","volume":"7","author":"A Sharif","year":"2012","unstructured":"Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7(8):1320\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1901_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.5500\/wjt.v13.i6.309","volume":"13","author":"JH Gorriceta","year":"2023","unstructured":"Gorriceta JH, Lopez Otbo A, Uehara G, Posadas Salas MA. BK viral infection: A review of management and treatment. World J Transplant. 2023;13(6):309\u201320.","journal-title":"World J Transplant"},{"issue":"5","key":"1901_CR14","first-page":"217","volume":"10","author":"M Mohammadi Najafabadi","year":"2020","unstructured":"Mohammadi Najafabadi M, Soleimani M, Ahmadvand M, Soufi Zomorrod M, Mousavi SA. Treatment protocols for BK virus associated hemorrhagic cystitis after hematopoietic stem cell transplantation. Am J Blood Res. 2020;10(5):217\u201330.","journal-title":"Am J Blood Res"},{"issue":"5","key":"1901_CR15","doi-asserted-by":"publisher","first-page":"e1005998","DOI":"10.1371\/journal.pcbi.1005998","volume":"14","author":"A Blazquez-Navarro","year":"2018","unstructured":"Blazquez-Navarro A, Schachtner T, Stervbo U, Sefrin A, Stein M, Westhoff TH, et al. Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach. PLoS Comput Biol. 2018;14(5):e1005998.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"1901_CR16","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1128\/JVI.80.7.3495-3505.2006","volume":"80","author":"Y Chen","year":"2006","unstructured":"Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, Kuroda MJ, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol. 2006;80(7):3495\u2013505.","journal-title":"J Virol"},{"issue":"2","key":"1901_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/TP.0b013e31815fef56","volume":"85","author":"SE Prosser","year":"2008","unstructured":"Prosser SE, Orentas RJ, Jurgens L, Cohen EP, Hariharan S. Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis. Transplantation. 2008;85(2):185\u201392.","journal-title":"Transplantation"},{"issue":"1","key":"1901_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells8010047","volume":"8","author":"G Ottaviano","year":"2019","unstructured":"Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, et al. Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation. Cells. 2019;8(1):47.","journal-title":"Cells"},{"issue":"22","key":"1901_CR19","first-page":"5745","volume":"4","author":"AS Nelson","year":"2020","unstructured":"Nelson AS, Heyenbruch D, Rubinstein JD, Sabulski A, Jodele S, Thomas S, et al. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients. Blood Adv. 2020;4(22):5745\u201354.","journal-title":"Blood Adv [Internet]"},{"issue":"24","key":"1901_CR20","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1200\/JCO.20.02608","volume":"39","author":"A Olson","year":"2021","unstructured":"Olson A, Lin R, Marin D, Rafei H, Bdaiwi MH, Thall PF, et al. Third-party BK virus-specific cytotoxic t lymphocyte therapy for hemorrhagic cystitis following allotransplantation. J Clin Oncol Off J Am Soc Clin Oncol. 2021;39(24):2710\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"9","key":"1901_CR21","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.ajt.2024.04.009","volume":"24","author":"R Khoury","year":"2024","unstructured":"Khoury R, Grimley MS, Nelson AS, Leemhuis T, Cancelas JA, Cook E, et al. Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2024;24(9):1634\u201343.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"4","key":"1901_CR22","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1212\/NXI.0000000000001020","volume":"8","author":"F Hopfner","year":"2021","unstructured":"Hopfner F, M\u00f6hn N, Eiz-Vesper B, Maecker-Kolhoff B, Gottlieb J, Blasczyk R, et al. Allogeneic BK Virus-Specific T-Cell Treatment in 2 Patients With Progressive Multifocal Leukoencephalopathy. Neurol Neuroimmunol neuroinflammation. 2021;8(4):e1020.","journal-title":"Neurol Neuroimmunol neuroinflammation."},{"issue":"3","key":"1901_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15419","volume":"103","author":"F Rudilla","year":"2024","unstructured":"Rudilla F, Carrasco-Benso MP, Pasamar H, L\u00f3pez-Monta\u00f1\u00e9s M, Andr\u00e9s-Rozas M, Tom\u00e1s-Mar\u00edn M, et al. Development and characterization of a cell donor registry for virus-specific T cell manufacture in a blood bank. HLA. 2024;103(3): e15419.","journal-title":"HLA [Internet]"},{"issue":"4","key":"1901_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/tan.13644","volume":"94","author":"E Enrich","year":"2019","unstructured":"Enrich E, Campos E, Martorell L, Herrero MJ, Vidal F, Querol S, et al. HLA-A, -B, -C, -DRB1, and -DQB1 allele and haplotype frequencies: An analysis of umbilical cord blood units at the Barcelona Cord Blood Bank. HLA. 2019;94(4):347\u201359.","journal-title":"HLA [Internet]"},{"issue":"12","key":"1901_CR25","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/v12121417","volume":"12","author":"M BurekKamenaric","year":"2020","unstructured":"BurekKamenaric M, Ivkovic V, KovacevicVojtusek I, Zunec R. The Role of HLA and KIR immunogenetics in BK Virus infection after kidney transplantation. Viruses. 2020;12(12):1417.","journal-title":"Viruses"},{"issue":"10","key":"1901_CR26","doi-asserted-by":"publisher","first-page":"eadt3499","DOI":"10.1126\/sciadv.adt3499","volume":"11","author":"MF Chevalier","year":"2025","unstructured":"Chevalier MF, Allain V, Gras J, Racle J, Villemonteix J, Divard G, et al. Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation. Sci Adv. 2025;11(10):eadt3499.\u00a0","journal-title":"Sci Adv [Internet]"},{"issue":"2","key":"1901_CR27","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.18632\/oncotarget.12387","volume":"8","author":"J Mani","year":"2017","unstructured":"Mani J, Wang L, H\u00fcckelhoven AG, Schmitt A, Gedvilaite A, Jin N, et al. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance. Oncotarget. 2017;8(2):2485\u2013500.","journal-title":"Oncotarget"},{"issue":"10","key":"1901_CR28","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1099\/vir.0.82094-0","volume":"87","author":"J Li","year":"2006","unstructured":"Li J, Melenhorst J, Hensel N, Rezvani K, Sconocchia G, Kilical Y, et al. T-cell responses to peptide fragments of the BK virus T antigen: Implications for cross-reactivity of immune response to JC virus. J Gen Virol. 2006;87(10):2951\u201360.","journal-title":"J Gen Virol"},{"key":"1901_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-4-47","volume":"4","author":"M Provenzano","year":"2006","unstructured":"Provenzano M, Bracci L, Wyler S, Hudolin T, Sais G, Gosert R, et al. Characterization of highly frequent epitope-specific CD45RA+\/CCR7+\/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors. J Transl Med. 2006;4:1\u201315.","journal-title":"J Transl Med"},{"issue":"2","key":"1901_CR30","first-page":"198","volume":"42","author":"Y Chen","year":"2009","unstructured":"Chen Y, Trofe J, Gordon J, Autissier P, Woodle ES, Koralnik IJ. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. ClinVirol. 2009;42(2):198\u2013202.","journal-title":"ClinVirol"},{"issue":"9","key":"1901_CR31","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.humimm.2009.05.003","volume":"70","author":"B Ramaswami","year":"2009","unstructured":"Ramaswami B, Popescu L, Macedo C, Metes D, Bueno M, Zeevi A, et al. HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen. Hum Immunol. 2009;70(9):722\u20138.","journal-title":"Hum Immunol"},{"issue":"4","key":"1901_CR32","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/ajt.13598","volume":"16","author":"M Cioni","year":"2016","unstructured":"Cioni M, Leboeuf C, Comoli P, Ginevri F, Hirsch HH. Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses. Am J Transplant. 2016;16(4):1193\u2013206.","journal-title":"Am J Transplant"},{"issue":"1","key":"1901_CR33","doi-asserted-by":"publisher","first-page":"e01102","DOI":"10.1002\/cti2.1102","volume":"9","author":"GR Ambalathingal","year":"2020","unstructured":"Ambalathingal GR, Francis RS, Corvino D, Srihari S, Aftab BT, Smith C, et al. Proteome-wide analysis of T-cell response to BK polyomavirus in healthy virus carriers and kidney transplant recipients reveals a unique transcriptional and functional profile. Clin Transl Immunol. 2020;9(1):e01102.","journal-title":"Clin Transl Immunol"},{"issue":"4","key":"1901_CR34","doi-asserted-by":"publisher","first-page":"e15722","DOI":"10.1111\/tan.15722","volume":"104","author":"AG Lara-de-Le\u00f3n","year":"2024","unstructured":"Lara-de-Le\u00f3n AG, Mora-Buch R, Cant\u00f3 E, Pe\u00f1a-G\u00f3mez C, Rudilla F. Identification of candidate immunodominant epitopes and Their HLA-binding prediction on BK polyomavirus proteins in healthy donors. HLA. 2024;104(4):e15722.","journal-title":"HLA [Internet]"},{"issue":"9","key":"1901_CR35","doi-asserted-by":"publisher","first-page":"572.e1","DOI":"10.1016\/j.jtct.2023.06.001","volume":"29","author":"R Mora-Buch","year":"2023","unstructured":"Mora-Buch R, Tom\u00e1s-Mar\u00edn M, Enrich E, Ant\u00f3n-Iborra M, Martorell L, Valdivia E, et al. Virus-specific T cells from cryopreserved blood during an emergent virus outbreak for a potential off-the-shelf therapy. Transplant Cell Ther. 2023;29(9):572.e1-572.e13.","journal-title":"Transplant Cell Ther [Internet]"},{"issue":"5","key":"1901_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/tan.12356","volume":"83","author":"JM Nunes","year":"2014","unstructured":"Nunes JM, Buhler S, Roessli D, Sanchez-Mazas A, Collaboration the H net 2013. The HLA-net GENE[RATE] pipeline for effective HLA data analysis and its application to 145 population samples from Europe and neighbouring areas. Tissue Antigens. 2014;83(5):307\u201323.","journal-title":"Tissue Antigens"},{"issue":"6","key":"1901_CR37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/597126","volume":"199","author":"A Egli","year":"2009","unstructured":"Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009;199(6):837\u201346.","journal-title":"J Infect Dis"},{"issue":"1","key":"1901_CR38","first-page":"270","volume":"6","author":"R Sajulga","year":"2022","unstructured":"Sajulga R, Bolon YT, Maiers MJ, Petersdorf EW. Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation. Blood Adv. 2022;6(1):270\u201380.","journal-title":"Blood Adv"},{"issue":"3","key":"1901_CR39","first-page":"362","volume":"136","author":"EW Petersdorf","year":"2020","unstructured":"Petersdorf EW, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, et al. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation. Blood. 2020;136(3):362\u20139.","journal-title":"Blood"},{"issue":"5","key":"1901_CR40","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/eji.1830270517","volume":"27","author":"V Braud","year":"1997","unstructured":"Braud V, Yvonne Jones E, McMichael A. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol. 1997;27(5):1164\u20139.","journal-title":"Eur J Immunol [Internet]"},{"issue":"3","key":"1901_CR41","doi-asserted-by":"publisher","first-page":"eaag1672","DOI":"10.1126\/sciimmunol.aag1672","volume":"1","author":"A Horowitz","year":"2016","unstructured":"Horowitz A, Djaoud Z, Nemat-Gorgani N, Blokhuis J, Hilton HG, B\u00e9ziat V, et al. Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol. 2016;1(3):eaag1672.","journal-title":"Sci Immunol"},{"issue":"5","key":"1901_CR42","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.jaci.2015.12.1311","volume":"137","author":"S Naik","year":"2016","unstructured":"Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016;137(5):1498-1505.e1.","journal-title":"J Allergy Clin Immunol [Internet]"},{"issue":"9","key":"1901_CR43","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.ajt.2024.05.003","volume":"24","author":"A Sempere","year":"2024","unstructured":"Sempere A, Castillo N, Rudilla F, Querol S, Enrich E, Prat-Vidal C, et al. Successful BK virus\u2013specific T cell therapy in a kidney transplant recipient with progressive multifocal leukoencephalopathy. Am J Transplant. 2024;24(9):1698\u2013702.","journal-title":"Am J Transplant [Internet]"},{"issue":"5","key":"1901_CR44","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1600-6143.2007.01754.x","volume":"7","author":"S Binggeli","year":"2007","unstructured":"Binggeli S, Egli A, Schaub S, Binet I, Mayr M, Steiger J, et al. Polyomavirus BK-specific cellular immune response to VP1 and Large T-antigen in kidney transplant recipients. Am J Transplant. 2007;7(5):1131\u20139.","journal-title":"Am J Transplant [Internet]"},{"issue":"3","key":"1901_CR45","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10875-021-01205-1","volume":"42","author":"FC Schulze Lammers","year":"2022","unstructured":"Schulze Lammers FC, Bonifacius A, Tischer-Zimmermann S, Goudeva L, Martens J, Lepenies B, et al. Antiviral T-cell frequencies in a healthy population: reference values for evaluating antiviral immune cell profiles in immunocompromised patients. J Clin Immunol. 2022;42(3):546\u201358.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1901_CR46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/TP.0b013e3181fe1335","volume":"91","author":"K Mueller","year":"2011","unstructured":"Mueller K, Schachtner T, Sattler A, Meier S, Friedrich P, Trydzenskaya H, et al. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation. 2011;91(1):100\u20137.","journal-title":"Transplantation"},{"issue":"3","key":"1901_CR47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1089\/vim.2007.0030","volume":"20","author":"W Zhou","year":"2007","unstructured":"Zhou W, Sharma M, Martinez J, Srivastava T, Diamond DJ, Knowles W, et al. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol. 2007;20(3):379\u201388.","journal-title":"Viral Immunol"},{"issue":"11","key":"1901_CR48","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1097\/TP.0b013e318234e0e5","volume":"92","author":"H Trydzenskaya","year":"2011","unstructured":"Trydzenskaya H, Sattler A, M\u00fcller K, Schachtner T, Dang-Heine C, Friedrich P, et al. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-Specific T-cell immunity. Transplantation. 2011;92(11):1269.","journal-title":"Transplantation"},{"issue":"10","key":"1901_CR49","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/TP.0b013e31823328c0","volume":"92","author":"E Blyth","year":"2011","unstructured":"Blyth E, Clancy L, Simms R, Gaundar S, O\u2019Connell P, Micklethwaite K, et al. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses. Transplantation. 2011;92(10):1077.","journal-title":"Transplantation"},{"issue":"2","key":"1901_CR50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1399-3062.2006.00167.x","volume":"8","author":"P Comoli","year":"2006","unstructured":"Comoli P, Binggeli S, Ginevri F, Hirsch HH. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl Infect Dis an Off J Transplant Soc. 2006;8(2):86\u201394.","journal-title":"Transpl Infect Dis an Off J Transplant Soc"},{"issue":"31","key":"1901_CR51","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","volume":"35","author":"I Tzannou","year":"2017","unstructured":"Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, et al. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(31):3547\u201357.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1901_CR52","doi-asserted-by":"crossref","unstructured":"Koldehoff M, Eiz-Vesper B, Maecker-Kolhoff B, Steckel NK, Dittmer U, Horn PA, et al. (2023) Long-term follow-up after adoptive transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients 11","DOI":"10.3390\/vaccines11040845"},{"issue":"242","key":"1901_CR53","doi-asserted-by":"publisher","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","volume":"6","author":"A Papadopoulou","year":"2014","unstructured":"Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C, et al. Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. Sci Transl Med. 2014;6(242):242ra83.","journal-title":"Sci Transl Med."},{"key":"1901_CR54","doi-asserted-by":"publisher","first-page":"720952","DOI":"10.3389\/fimmu.2021.720952","volume":"12","author":"H Jacobsen","year":"2021","unstructured":"Jacobsen H, Klein SL. Sex differences in immunity to viral infections. Front Immunol. 2021;12:720952.","journal-title":"Front Immunol"},{"issue":"6","key":"1901_CR55","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/ajt.12689","volume":"14","author":"T Schmidt","year":"2014","unstructured":"Schmidt T, Adam C, Hirsch HH, Janssen MWW, Wolf M, Dirks J, et al. BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2014;14(6):1334\u201345.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"issue":"10185","key":"1901_CR56","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","volume":"393","author":"FG Scurt","year":"2019","unstructured":"Scurt FG, Ewert L, Mertens PR, Haller H, Schmidt BMW, Chatzikyrkou C. Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis. Lancet (London, England). 2019;393(10185):2059\u201372.","journal-title":"Lancet (London, England)"},{"issue":"8","key":"1901_CR57","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2215\/CJN.00540118","volume":"13","author":"AE de Weerd","year":"2018","unstructured":"de Weerd AE, Betjes MGH. ABO-incompatible kidney transplant outcomes: a meta-analysis. Clin J Am Soc Nephrol. 2018;13(8):1234\u201343.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1901_CR58","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.ekir.2024.04.003","volume":"9","author":"M Eder","year":"2024","unstructured":"Eder M, Schrag TA, Havel EF, Kainz A, Omic H, Doberer K, et al. Polyomavirus nephropathy in ABO blood group-incompatible kidney transplantation: torque teno virus and immunosuppressive burden as an approximation to the problem. Kidney Int reports. 2024;9(6):1730\u201341.","journal-title":"Kidney Int reports"},{"issue":"1","key":"1901_CR59","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1186\/s12879-023-08792-x","volume":"23","author":"EA Butler","year":"2023","unstructured":"Butler EA, Parikh R, Grandi SM, Ray JG, Cohen E. ABO and Rh blood groups and risk of infection: systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):797.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1901_CR60","doi-asserted-by":"publisher","first-page":"e2298","DOI":"10.1002\/brb3.2298","volume":"11","author":"P Frenken","year":"2021","unstructured":"Frenken P, Hartung HP, Olsson T, Adams O, Warnke C. Type O blood group associates with higher anti-JC polyomavirus antibody levels. Brain Behav. 2021;11(8):e2298.","journal-title":"Brain Behav"},{"issue":"10","key":"1901_CR61","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamaneurol.2013.3932","volume":"70","author":"MN Khoury","year":"2013","unstructured":"Khoury MN, Mittleman MA, Koralnik IJ. ABO Blood Groups and Risk for Progressive Multifocal Leukoencephalopathy. JAMA Neurol. 2013;70(10):1331\u20132.","journal-title":"JAMA Neurol"},{"issue":"2","key":"1901_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41435-022-00169-5","volume":"23","author":"JA Sugrue","year":"2022","unstructured":"Sugrue JA, Smith M, Posseme C, Charbit B, Abel L, Alcover A, et al. Rhesus negative males have an enhanced IFN\u03b3-mediated immune response to influenza A virus. Genes Immun. 2022;23(2):93\u20138.","journal-title":"Genes Immun"},{"issue":"12","key":"1901_CR63","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","volume":"200","author":"G Picarda","year":"2018","unstructured":"Picarda G, Benedict CA. Cytomegalovirus: Shape-Shifting the Immune System. J Immunol. 2018;200(12):3881\u20139.","journal-title":"J Immunol"},{"key":"1901_CR64","doi-asserted-by":"publisher","first-page":"1482329","DOI":"10.3389\/fviro.2024.1482329","volume":"4","author":"F Ebrahimi","year":"2024","unstructured":"Ebrahimi F, Rasizadeh R, Sharaflou S, Aghbash PS, Shamekh A, Jafari-Sales A, et al. Coinfection of EBV with other pathogens: a narrative review. Front Virol. 2024;4:1482329.","journal-title":"Front Virol"},{"issue":"Suppl 2","key":"1901_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/tan.13645","volume":"94","author":"I Kovacevic Vojtusek","year":"2019","unstructured":"Kovacevic Vojtusek I, Burek Kamenaric M, Ivkovic V, Bulimbasic S, Marekovic I, Coric M, et al. Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients. HLA. 2019;94(Suppl 2):4\u201310.","journal-title":"HLA"},{"issue":"12","key":"1901_CR66","first-page":"3119","volume":"28","author":"K Masutani","year":"2013","unstructured":"Masutani K, Ninomiya T, Randhawa P. HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2013;28(12):3119\u201326.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"8","key":"1901_CR67","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/cells8080847","volume":"8","author":"H Rohn","year":"2019","unstructured":"Rohn H, Michita RT, Schramm S, Dolff S, G\u00e4ckler A, Korth J, et al. HLA-E polymorphism determines susceptibility to BK Virus nephropathy after living-donor kidney transplant. Cells. 2019;8(8):847.","journal-title":"Cells"},{"issue":"6669","key":"1901_CR68","first-page":"795","volume":"391","author":"VM Braud","year":"1998","unstructured":"Braud VM, Allan DS, O\u2019Callaghan CA, S\u00f6derstr\u00f6m K, D\u2019Andrea A, Ogg GS, et al. HLA-E binds to natural killer cell receptors CD94\/NKG2A. B and C Nature. 1998;391(6669):795\u20139.","journal-title":"B and C Nature"},{"issue":"11","key":"1901_CR69","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.4049\/jimmunol.157.11.4741","volume":"157","author":"S Lazetic","year":"1996","unstructured":"Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 1996;157(11):4741\u20135.","journal-title":"J Immunol"},{"issue":"8","key":"1901_CR70","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1158\/2326-6066.CIR-18-0885","volume":"7","author":"M Abd Hamid","year":"2019","unstructured":"Abd Hamid M, Wang RZ, Yao X, Fan P, Li X, Chang XM, et al. Enriched HLA-E and CD94\/NKG2A interaction limits antitumor cd8+ tumor-infiltrating T Lymphocyte Responses. Cancer Immunol Res. 2019;7(8):1293\u2013306.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"1901_CR71","doi-asserted-by":"publisher","first-page":"1986943","DOI":"10.1080\/2162402X.2021.1986943","volume":"10","author":"L Gimeno","year":"2021","unstructured":"Gimeno L, Gonz\u00e1lez-Lozano I, Soto-Ram\u00edrez MF, Mart\u00ednez-S\u00e1nchez MV, L\u00f3pez-Cubillana P, Fuster JL, et al. CD8+ T lymphocytes are sensitive to NKG2A\/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021;10(1):1986943.","journal-title":"Oncoimmunology"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01901-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01901-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:01:49Z","timestamp":1777309309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01901-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01901-2","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Vall d\u2019Hebron University Hospital (Project PR [BST] 530\/2018; Protocol code: RTC-2017\u20136368-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All donors included in this study met the eligibility criteria established by the blood bank and provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed consent was obtained from all participants included in the study. No identifying information from individual participants is included.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}